Functional differences between CLL‐ and ALL‐derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL‐10 as potential modulatory targets. The gene discussed is CXCR4; the disease is B-cell chronic lymphocytic leukemia.